News Focus
News Focus
icon url

ratobranco

08/28/11 3:36 PM

#972 RE: Koufax #971

HRT - It's definitely an interesting name. However, based on research publications I've received from Fernando, OGX appears to be a better risk-reward in terms of upside at current share prices.
icon url

Koufax

09/13/11 11:20 AM

#991 RE: Koufax #971

HRT

I stuck my toe in the water.

Of concern: The company's slide show and most recent conference call indicates R$2.2B in cash, whereas R$1.3 is pledged to secure bank letters of credit issued in connection with the company's option to purchase a 45% interest in one of its exploration plays. If that option is exercised, the cash will be gone and the company will only have about one year of cash left. Expect dilution. Worse, expect overly optimistic investor presentations. Nonetheless, the potential is very large.